X4 Pharmaceuticals (XFOR) Receivables - Other (2017 - 2025)
X4 Pharmaceuticals (XFOR) reported Receivables - Other of $715000.0 for Q3 2025, down 33.36% on a YoY basis from $1.1 million in Q3 2024, and down 0.69% quarter-over-quarter from $720000.0 in Q2 2025.
X4 Pharmaceuticals (XFOR) Receivables - Other (2017 - 2025) Analysis & Trends
X4 Pharmaceuticals has reported Receivables - Other for 9 years, with the latest figure at $715000.0 in Q3 2025.
- For the quarter ending Q3 2025, Receivables - Other fell 33.36% year-over-year to $715000.0; the trailing twelve-month figure through Sep 2025 stood at $715000.0 (down 33.36% YoY), and the FY2024 full-year result was $640000.0, up 13.88% from the prior year.
- Receivables - Other for Q3 2025 stood at $715000.0, down from $720000.0 in the prior quarter.
- The five-year high for Receivables - Other was $1.2 million in Q4 2022, with the low at $393000.0 in Q3 2023.
- Historically, Receivables - Other has averaged $778315.8 across 5 years, with a median of $747000.0 in 2021.
- Annual changes were most pronounced in 2023 — Receivables - Other plunged 56.77% — and 2024, when it surged 173.03%.
- X4 Pharmaceuticals' Receivables - Other stood at $747000.0 in 2021, then surged by 54.22% to $1.2 million in 2022, then plunged by 51.22% to $562000.0 in 2023, then climbed by 13.88% to $640000.0 in 2024, then rose by 11.72% to $715000.0 in 2025.
- The last three Receivables - Other figures came in at $715000.0 (Q3 2025), $720000.0 (Q2 2025), and $665000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | X4 Pharmaceuticals | 156.06 Mn | 156.06 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 715,000.00 |
| Sep 30, 2025 | 715,000.00 |
| Jun 30, 2025 | 720,000.00 |
| Jun 30, 2025 | 720,000.00 |
| Mar 31, 2025 | 665,000.00 |
| Mar 31, 2025 | 665,000.00 |
| Dec 31, 2024 | 640,000.00 |
| Dec 31, 2024 | 640,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 854,000.00 |
| Jun 30, 2024 | 854,000.00 |
| Mar 31, 2024 | 702,000.00 |
| Mar 31, 2024 | 702,000.00 |
| Dec 31, 2023 | 562,000.00 |
| Dec 31, 2023 | 562,000.00 |
| Sep 30, 2023 | 393,000.00 |
| Sep 30, 2023 | 393,000.00 |
| Jun 30, 2023 | 820,000.00 |
| Jun 30, 2023 | 820,000.00 |